# FDA Inspection 986283 - Carter Bloodcare - Allen - August 10, 2016

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-allen/ba3d79cc-9a94-4e0d-9420-a7242f57ce49
Source feed: FDA_Inspections

> FDA Inspection 986283 for Carter Bloodcare - Allen on August 10, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 986283
- Company Name: Carter Bloodcare - Allen
- Inspection Date: 2016-08-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1194883 - 2023-01-18](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-allen/f6e9f3a8-a309-4126-9fd9-8204b623183f)
- [FDA Inspection 1194883 - 2023-01-18](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-allen/33adcbd1-8267-4351-b481-8b084c701370)
- [FDA Inspection 1067548 - 2018-09-11](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-allen/1ff5061a-4ece-4908-8e88-f9bef2ec0d98)
- [FDA Inspection 867621 - 2014-02-25](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-allen/9d336559-8bd8-4a7b-8e6e-c8270b21d6db)
- [FDA Inspection 799646 - 2012-09-18](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-allen/e7080a24-cb1b-4b29-99df-9647346c58ab)

Company: https://www.keypedia.com/companies/carter-bloodcare-allen/319dbca9-18e0-49f9-8088-a327c6576634

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d